Papers
5
Total Citations
64
H-Index
5
About
Dr. Kristin Bixel is a gynecologic oncologist whose research centers on optimizing surgical outcomes for women with gynecologic cancers, particularly cervical and endometrial malignancies. She is best known for her leadership in the landmark ROCC/GOG-3043 trial (2022, 24 citations), a randomized non-inferiority study comparing robotic versus open radical hysterectomy for early-stage cervical cancer. This work directly addresses the critical safety questions raised by the 2018 LACC trial, which found worse outcomes with laparoscopic surgery. Dr. Bixel’s research has also advanced understanding of surgical approach determinants and survival in endometrial carcinoma (2021, 17 citations), and she developed a validated readmission risk score for robotic hysterectomy patients (2021, 10 citations). Her investigations into fertility-sparing surgery for early cervical cancer (2019, 5 citations) further demonstrate her commitment to balancing oncologic safety with quality of life. Through these contributions, Dr. Bixel has helped shape evidence-based guidelines for minimally invasive gynecologic oncology surgery, improving perioperative safety and long-term outcomes for thousands of women.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5